Unverified50% confidenceFactExact time
PostEra is a Y Combinator W20 incubated company whose core business revolves around machine learning and chemical synthesis, with technical approaches including machine learning prediction of chemical reaction outcomes and AI drug molecule design (especially antiviral drug development).
1
Sources
50%
Confidence
Long-term
Relevance
10/13/2026
First Seen
Sources
Related Entities
Related Claims
VerifiedxAI is an AI research company founded by Musk in 2023 and owns the Grok series of large models.54% similarVerifiedDETR was proposed by Facebook AI Research in 2020 and was the first to introduce the Transformer architecture into object detection, eliminating the need for anchor boxes and NMS post-processing53% similarUnverifiedThe US FDA published the "Artificial Intelligence/Machine Learning-Based Software as a Medical Device Action Plan" in 2021, introducing the concept of a Predetermined Change Control Plan.53% similarUnverifiedIn 2024, FSD was upgraded to V12, a version based on an end-to-end neural network, marking a shift from a rule-based coding approach to a data-driven AI decision model.52% similarUnverifiedIn 2024, the U.S. Department of Commerce implemented export controls on advanced AI chips, primarily targeting training hardware such as the H100.52% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1021855API
curl https://kongchang.com/api/v1/knowledge/claims/1021855MCP
get_claim(id=1021855)